- Two Cases of Interstitial Pneumonitis Caused by Rituximab Therapy
-
Lee Y, Kyung SY, Choi SJ, Bang SM, Jeong SH, Shin DB, Lee JH
- KMID: 759845
- Korean J Intern Med.
- 2006 Sep;21(3):183-186.
- doi: 10.3904/kjim.2006.21.3.183
Rituximab, a chimeric monoclonal antibody directed against CD20, has become a part of the standard therapy for patients with non-Hodgkin's lymphoma either in combination with other drugs or as a... -
- CITED
-
- Close
- SHARE
-
- Close
- Severe Acneiform Eruption Induced by Cetuximab (Erbitux(R))
-
Lee JE, Lee SJ, Lee HJ, Lee JH, Lee KH
- KMID: 2158205
- Yonsei Med J.
- 2008 Oct;49(5):851-852.
- doi: 10.3349/ymj.2008.49.5.851
Epidermal growth factor has an important role in the regulation of proliferation and differentiation in epidermal keratinocytes, as well as in the survival, angiogenesis and metastasis of cancer cells. Cetuximab... -
- CITED
-
- Close
- SHARE
-
- Close
- Hemorrhagic pericarditis with cardiac tamponade after percutaneous coronary intervention associated with the use of abciximab
-
Moon SJ, Yoon HJ, Her SH, Lee JM, An HJ, Lee YJ, Jin SW
- KMID: 759974
- Korean J Intern Med.
- 2008 Sep;23(3):156-160.
- doi: 10.3904/kjim.2008.23.3.156
Glycoprotein (GP) IIb/IIIa inhibitors, such as abciximab, are used as adjunctive therapy for percutaneous coronary intervention (PCI) in high-risk non-ST-elevation myocardial infarction (NSTEMI) and in ST-elevation myocardial infarction (STEMI), although... -
- CITED
-
- Close
- SHARE
-
- Close
- A Case of Psoriasis Induced by Infliximab Treatment for Crohn's Disease
-
Jwa YJ, Kim NH, Park HJ, Park JS, Bae WK, Kim KA, Lee JS, Moon YS
- KMID: 1718375
- Korean J Gastroenterol.
- 2010 Nov;56(5):324-328.
- doi: 10.4166/kjg.2010.56.5.324
Infliximab, the monoclonal antibody to tumor necrosis factor, is indicated for refractory luminal and fistulizing Crohn's disease and rheumatoid arthritis. Infliximab treatment has adverse events including infusion reactions, opportunistic infections,... -
- CITED
-
- Close
- SHARE
-
- Close
- A Rare Case of Free Bowel Perforation Associated with Infliximab Treatment for Stricturing Crohn's Disease
-
Lim CS, Moon W, Park SJ, Park MI, Kim HH, Kim JB, Choi JM, Chang HK, Lee SH
- KMID: 1707200
- Korean J Gastroenterol.
- 2013 Sep;62(3):169-173.
- doi: 10.4166/kjg.2013.62.3.169
Crohn's disease is characterized by chronic transmural inflammation of the bowel and is associated with serious complications, such as bowel strictures, abscesses, fistula formation, and perforation. As neither medical nor... -
- CITED
-
- Close
- SHARE
-
- Close
- Rituximab-CHOP Induced Interstitial Pneumonitis in Patients with Disseminated Extranodal Marginal Zone B Cell Lymphoma
-
Kim KM, Kim HC, Jeon KN, Kim HG, Kang JH, Hahm JR, Lee GW
- KMID: 2396100
- Yonsei Med J.
- 2008 Feb;49(1):155-158.
A 69-year-old male was diagnosed in February 2004 with stage IV extranodal marginal zone B cell lymphoma involving the mediastinal nodes, lung parenchyma and bone marrow with high LDH. Shortness... -
- CITED
-
- Close
- SHARE
-
- Close
- Adenoviral Pneumonia During Etanercept Treatment in a Patient with Rheumatoid Arthritis
-
Kang MJ, Kim MS, Choi EH, Lee KE, Kim YK, Choi HJ
- KMID: 1717999
- Korean J Intern Med.
- 2007 Mar;22(1):63-66.
- doi: 10.3904/kjim.2007.22.1.63
Inhibitors of tumor necrosis factor-alpha (TNF-alpha) have been approved for treating rheumatoid arthritis. As one of the biological response modifiers, etanercept has also been used in the treatment of psoriatic... -
- CITED
-
- Close
- SHARE
-
- Close
- Follow-up Testing of Interferon-Gamma Release Assays Are Useful in Ankylosing Spondylitis Patients Receiving Anti-Tumor Necrosis Factor Alpha for Latent Tuberculosis Infection
-
Son CN, Jun JB, Kim JH, Sung IH, Yoo DH, Kim TH
- KMID: 2129603
- J Korean Med Sci.
- 2014 Aug;29(8):1090-1093.
- doi: 10.3346/jkms.2014.29.8.1090
We evaluated the utility of follow-up interferon-gamma release assays (IGRAs) for the diagnosis of reactivation of latent tuberculosis infection (LTBI) or new tuberculosis in ankylosing spondylitis (AS) patients receiving anti-tumor... -
- CITED
-
- Close
- SHARE
-
- Close
